Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 8,044,088

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,044,088
Title:1-acetic acid-indole derivatives with PGD2 antagonist activity
Abstract: Compounds of general formula (I) ##STR00001## wherein R.sup.1 is halo or cyano; R.sup.2 is C.sub.1-C.sub.4 alkyl; and R.sup.3 is phenyl substituted with one or more substituents chosen from C.sub.1-C.sub.6 alkyl, halo or --SO.sub.2(C.sub.1-C.sub.6 alkyl); or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof; are useful in the treatment of diseases and conditions mediated by the action of PGD.sub.2 at the CRTH2 receptor.
Inventor(s): Armer; Richard Edward (Cambridge, GB), Boyd; Edward Andrew (Henfield, GB), Boyd, legal representative; Judith Helen (Henfield, GB), Hay; Philip Andrew (Scarborough, GB)
Assignee: Oxagen Limited (Abingdon, GB)
Application Number:11/908,401
Patent Claims:see list of patent claims

Details for Patent 8,044,088

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. XOLAIR omalizumab For Injection 103976 2003-06-20 ⤷  Try it Free 2025-03-11
Genentech, Inc. XOLAIR omalizumab Injection 103976 2018-09-28 ⤷  Try it Free 2025-03-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.